1. Analysis of behavior-related adverse experiences in clinical trials of montelukast 
George Philip, MD, Carolyn M. Hustad, PhD, Marie-Pierre Malice, PhD, Gertrude Noonan, BA, Alan Ezekowitz, MBChB, D Phil, Theodore F. Reiss, MD, Barbara Knorr, MD 
Journal of Allergy and Clinical Immunology 
Volume 124, Issue 4, Pages e8 (October 2009)
DOI: /j.jaci
Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2. Fig 1
Patients with BRAEs. Plot showing the ORs and 95% CIs for all BRAEs, Psych-SOC plus OtherSelectPTs, and Akath-PTs.
Journal of Allergy and Clinical Immunology  , e8DOI: ( /j.jaci )
Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3. Time to discontinuation: Kaplan-Meier cumulative incidence of discontinuation for any reason for patients included in the analysis of BRAEs.
Journal of Allergy and Clinical Immunology  , e8DOI: ( /j.jaci )
Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions